DHR vs HD: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and The Home Depot, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction Grade B High Quality
VS
The Home Depot, Inc. · Consumer Cyclical
$292.18
+44.2% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
HD has more upside to fair value (+44.2%). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric DHR HD
Current Price $221.12 $292.18
Fair Value Estimate $286.52 $421.26
Upside to Fair Value +29.6% +44.2%
Market Cap $155.4B $291.3B
Forward P/E — —
EV / EBITDA 24.8x 14.7x
Price / Sales 6.2x 1.7x
Price / FCF 28.5x 19.2x
Revenue Growth YoY +5.5% +5.7%
Gross Margin 58.5% 33.2%
Operating Margin 20.4% 12.4%
Return on Equity 7.7% 102.7%
Dividend Yield 0.65% 3.18%
FCF Yield 3.51% 5.2%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR — Danaher Corporation
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
HD — The Home Depot, Inc.
The Home Depot is the largest home-improvement retailer in the United States, operating a network of roughly 2,300 stores supported by about 472,400 full-time employees, and serving both do-it-yourself homeowners and professional contractors through stores, homedepot.com, and specialty sites such as blinds.com. The business quality is high: it generates a 102.7% return on equity, a 33.2% trailing…
Accumulation Zones
Metric DHR HD
Zone Low $214.89 $315.94
Zone High $243.54 $358.07
In Buy Zone? Yes Yes
← DHR Research    HD Research →    All Research